sotalol has been researched along with Body Weight, Fetal in 1 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Excerpt | Relevance | Reference |
---|---|---|
"Sotalol is a beta-adrenoceptor blocking drug which also has class III antiarrhythmic properties via Ikr channel blockade." | 1.31 | Developmental toxicity in the pregnant rabbit by the class III antiarrhythmic drug sotalol. ( Danielsson, BR; Sköld, AC, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sköld, AC | 1 |
Danielsson, BR | 1 |
1 other study available for sotalol and Body Weight, Fetal
Article | Year |
---|---|
Developmental toxicity in the pregnant rabbit by the class III antiarrhythmic drug sotalol.
Topics: Animals; Anti-Arrhythmia Agents; Area Under Curve; Embryo Loss; Embryonic and Fetal Development; Fem | 2001 |